BAX : Analysis & Opinions

  1. Will Baxter International (BAX) Disappoint Earnings in Q4? - ...

    January 27, 2015
    Baxter International Inc. (BAX) is set to report fourth-quarter 2014 results on Jan 29.
  2. Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst ...

    January 26, 2015
    Pfizer's (PFE) Prevenar 13 is a step closer to EU approval with the CHMP giving a favorable opinion for the prevention of ...
  3. CareFusion Banks on Pipeline Strength, Pricing Woes Remain - ...

    January 26, 2015
    We note that CareFusion Corp (CFN) highly relies on innovation to develop new and differentiated products.
  4. Merrimack Reveals Additional Data from Oncology Candidate - Analyst ...

    January 22, 2015
    Merrimack (MACK) announced additional analyses from the phase III NAPOLI-1 study on MM-398 .
  5. Baxter's (BAX) PHOXILLUM Solutions Get FDA Nod for CRRT - Analyst ...

    January 21, 2015
    Baxter International Inc. (BAX) expects the PHOXILLUM phosphate-containing solutions to be available in the U.S. from the ...
  6. NxStage Revises Up 2014 Guidance on Strong Home Growth - Analyst ...

    January 14, 2015
    NxStage Medical Inc. (NXTM) revised its fourth quarter and full year 2014 guidance.
  7. Pfizer Boosts Vaccine Pipeline with Redvax Acquisition - Analyst ...

    January 7, 2015
    Pfizer's (PFE) acquisition of Redvax makes the company one of the leaders in CMV research and development.
  8. Nxstage Medical's Home Dialysis System Gets FDA Go-Ahead - Analyst ...

    December 24, 2014
    Nxstage Medical, Inc.'s (NXTM) System One is cleared by the FDA to perform hemodialysis overnight while the patient is at ...
  9. Baxter Seeks FDA Approval of BAX111 to Advance VWD Cure - Analyst ...

    December 23, 2014
    Baxter International Inc. (BAX) filed a BLA with the FDA for the approval of BAX 111 - an investigational drug for the treatment ...
  10. Baxter to Vend Vero Cell Vaccine Platform to Nanotherapeutics ...

    December 16, 2014
    Baxter International Inc (BAX) is set to divest its Vero cell technology and related assets to Nanotherapeutics, Inc for ...
  11. Will MedTech Gain from Republican Promises? - Industry Outlook

    December 4, 2014
    Will MedTech Gain from Republican Promises? - Industry Outlook
  12. MedTech Defies Sequestration, M&As Steal the Show - Industry ...

    August 26, 2014
    MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
  13. MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

    May 1, 2014
    MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
  14. Strategic Beta ETFs

    February 27, 2014
    Strategic Beta ETFs By Greg McFarlane As the financial markets get more sophisticated and arcane with time, the number of ...
  15. MedTech Industry Stock Update - Jan 2014 - Industry Outlook

    January 7, 2014
    MedTech Industry Stock Update - Jan 2014 - Industry Outlook
  16. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  17. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    September 14, 2013
    Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
  18. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  19. Trend Channel Bounce Trades

    August 7, 2013
    These stocks are in strong upward trend channels, but are currently trading near the lower support line. If the channel holds, ...
  20. 4 High Yield, Low Beta Stocks - Investment Ideas

    January 10, 2013
    Decades from now, economic historians will look back at this period as the era of exceptionably low interest rates. Just ...
  21. A Look Back At The Year In Medical Technology

    December 28, 2012
    Med-tech had an up-and-down year as product-specific stories did battle with sluggish macro conditions.
  22. Will Baxter Go For Gambro?

    November 26, 2012
    Baxter may be about to conclude its long pursuit of Gambro
  23. Becton Dickinson Safe And Steady

    June 13, 2012
    Becton stands out for having one of the clearest growth strategies in its field as well as a solid track record of delivering ...
  24. CareFusion: Is It Still Cheap?

    May 3, 2012
    The biggest concern investors have with CareFusion is its low return on invested capital. Until it creates higher free cash ...
  25. OM Group - Just Another Cheap Commodity Play, Or Something More?

    January 17, 2012
    OM Group is seeing multiple cyclical downturns, but looks cheap.
  26. 2011 - Another Sick Year For Larger Med-Tech

    December 29, 2011
    Larger healthcare companies are still getting sickly returns in the market.
  27. Hill-Rom: Litigation Equals Opportunity For Investors

    December 23, 2011
    Hill-Rom's $42 million litigation settlement in September knocked its stock down more than 30%, providing investors with ...
  28. SonoSite Finds Its Deal

    December 20, 2011
    SonoSite finally finds its buyer.
  29. If CareFusion Can Execute, This Is A Major Bargain

    November 9, 2011
    CareFusion has to make some improvements, but it could really reward investors.
  30. Abbott Labs Joins The Separation Movement

    October 24, 2011
    Abbott is joining the separation movement that is sweeping across corporate America. The company plans to break into a medical ...
  31. BD Healthy, But No Great Bargain

    August 9, 2011
    BD is not the cheapest health care name, but it comes with a lot of quality.
  32. Three Safe Sectors For The Summer

    July 11, 2011
    With uncertainty beginning to creep back into the markets, investors may want to take a defensive posture.
  33. Great Dividend Payers In Medical Technology

    May 21, 2010
    Dividend-paying stocks are not common in medical technology, but these four proven winners deliver the goods.
  34. Becton Dickinson More Interesting Than You Think

    May 3, 2010
    Becton Dickinson is often dismissed as "boring" but a diversified cash-generating business with real growth shouldn't be.
  35. Small Med-Tech Names You Should Know

    April 15, 2010
    These three med-tech names aren't well-known by most investors, but they should be.
  36. Quality Stocks To Play Defense With

    November 5, 2009
    These three high-quality stocks are a great way to add some defense to your investment team.
  37. Swine Flu Vaccine: Quantity Over Quality

    July 20, 2009
    The swine flu vaccine race appears to have multiple winners.
  38. Baxter A Healthy Healthcare Holding

    April 22, 2009
    Baxter's recent results demonstrate why it continues as a leader in its industry and should be considered a core healthcare ...
  39. Medical Devices: Cure For Ailing Portfolios?

    February 27, 2009
    Find out how these medical device makers may resuscitate your ailing portfolio.
  40. Will Emergent BioSolutions Finally Retreat?

    January 12, 2009
    Having lost positive earnings and revenue momentum, EBS is looking less healthy in 2009.
  41. Baxter International: Bullish Chart Of The Day

    June 30, 2008
    The recent break above the resistance level will likely cause increased buying pressure.
  42. Five Stocks For The Socially Responsible Investor

    June 25, 2008
    Making money in the market shouldn't prevent you from sleeping at night. Find out how to keep your conscience clean and bank ...
  43. Making A Difference In Dialysis (FMS,DVA,NXTM)

    August 16, 2007
    Treating renal failure is serious business. With so many Baby Boomers in America, it's also one that isn't going away.
Trading Center